Literature DB >> 6233346

Outcomes on lithium treatment as a tool for genetic studies in affective disorders.

E Smeraldi, A Petroccione, M Gasperini, F Macciardi, A Orsini, K K Kidd.   

Abstract

From a genetic point of view, the application of mathematical models to affective disorders has not yet been useful, since they do not indicate a specific mode of transmission. To use these models correctly, we need to identify homogeneous genetic subgroups among those sharing the common phenotypic feature of affective illness. Our useful criterion for this is outcome on long-term lithium therapy, since experimental data suggest the existence of a close relationship between the genetic mechanisms that underly the affective disorders and those that underly outcome on lithium. We have studied 145 subjects with primary affective disorders, 92 of whom did not relapse during lithium treatment and 53 of whom did, together with 864 of their first-degree relatives. The data for both groups fit both single major locus and multifactorial polygenic models for genetic analysis, including a sex effect and therefore neither mode of transmission can be excluded.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233346     DOI: 10.1016/0165-0327(84)90019-3

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

Review 1.  Pharmacogenetics of lithium response in bipolar disorder.

Authors:  M Alda
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

2.  Antidepressant-like responses to lithium in genetically diverse mouse strains.

Authors:  A Can; R A Blackwell; S C Piantadosi; D T Dao; K C O'Donnell; T D Gould
Journal:  Genes Brain Behav       Date:  2011-03-01       Impact factor: 3.449

3.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

Review 4.  Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.

Authors:  Firoza Mamdani; Iris Jaitovich Groisman; Martin Alda; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

5.  Differential antidepressant-like response to lithium treatment between mouse strains: effects of sex, maternal care, and mixed genetic background.

Authors:  Adem Can; Sean C Piantadosi; Todd D Gould
Journal:  Psychopharmacology (Berl)       Date:  2013-03-17       Impact factor: 4.530

Review 6.  Molecular actions and clinical pharmacogenetics of lithium therapy.

Authors:  Adem Can; Thomas G Schulze; Todd D Gould
Journal:  Pharmacol Biochem Behav       Date:  2014-02-15       Impact factor: 3.533

7.  Lithium: a key to the genetics of bipolar disorder.

Authors:  Cristiana Cruceanu; Martin Alda; Gustavo Turecki
Journal:  Genome Med       Date:  2009-08-19       Impact factor: 11.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.